S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LXEO Lexeo Therapeutics Inc

9.67

-0.20 (-2.03%)

Sep 13 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Lexeo Therapeutics (NASDAQ:LXEO)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Lexeo Therapeutics Charts.

Lexeo Therapeutics (NASDAQ:LXEO)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Lexeo Therapeutics Charts.

Lexeo Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 September 2024 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 10 September 2024 (5 days ago) • Edgar (US Regulatory)

Lexeo Therapeutics to Participate in Upcoming Investor Conferences
Thursday 5 September 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 13 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 12 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 12 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 12 August 2024 (1 month ago) • Edgar (US Regulatory)

Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights
Monday 12 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 15 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 15 July 2024 (2 months ago) • Edgar (US Regulatory)

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Monday 15 July 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 12 July 2024 (2 months ago) • Edgar (US Regulatory)

More Lexeo Therapeutics Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions